Stinner Frameworks announces the launch of its new Carrizo All-Road bike which is part of the new handmade Stinner Select ...

Apex Legends Season 23 is all set to release on November 5, 2024. With just a few days left for a seasonal update, players who are yet to complete their Season 22 Battle Pass and any other ...

One of the most visible goldfish health problems has a very common cause. Take our advice to find out what to do if your goldfish starts to turn upside down. What is this problem and how can I ...

Getting the most out of your frames per second (FPS) is crucial in a competitive game like Apex Legends, and knowing how to set or remove your FPS cap can be the difference between winning or ...

Apex Legends Season 23 is on the horizon. Although there are many things that aren't confirmed about the next season, leakers have revealed information that will help you prepare for your next ...

Overactive bladder (OAB) is a group of symptoms that are not usually life-threatening but can significantly decrease productivity and quality of life. The condition is characterized by the sudden need ...

If so, that could be a possible cause of the persistent Apex Legends crashing on your PC. Try undoing any processor overclocking by selecting options that restore default settings within your ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

The withdrawal in metastatic urothelial carcinoma, an aggressive form of bladder cancer, does not affect the drug’s status in its other approved indications in the U.S. or other markets.

The setback in bladder cancer is a small disappointment, representing less than 10% of sales compared with 90% in breast cancer, TD Securities analyst Tyler Van Buren wrote in a note to clients. Van ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for bladder cancer in 2021, failed its confirmatory trial earlier this year. Gilead ...